Salvage Therapy with Vinorelbine in Advanced Non-Small-Cell Lung Cancer: A Retrospective Review of the Fox Chase Cancer Center Experience and a Review of the Literature

2007 ◽  
Vol 8 (5) ◽  
pp. 319-326 ◽  
Author(s):  
John G. Devlin ◽  
Corey J. Langer
Cancers ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 998
Author(s):  
Chiara Lazzari ◽  
Aurora Mirabile ◽  
Alessandra Bulotta ◽  
Maria Grazia Viganó ◽  
Francesca Rita Ogliari ◽  
...  

Several trials have tried for decades to improve the outcome of extensive disease small cell lung cancer (ED-SCLC) through attempts to modify the standard treatments. Nevertheless, platinum/etoposide combination and topotecan have remained respectively the first and the second line standard treatments for the last 40 years. With the advent of immunotherapy, this scenario has finally changed. Our review aims to provide an overview of the primary studies on the actual therapeutic strategies available for ED-SCLC patients, and to highlight emerging evidence supporting the use of immunotherapy in SCLC patients.


Lung Cancer ◽  
2003 ◽  
Vol 41 ◽  
pp. S137
Author(s):  
Jian-Sheng Jan ◽  
Jin-Ching Lin ◽  
Yih-Chyang Wen ◽  
Lilly Wang ◽  
Jih-Yi Chen

Sign in / Sign up

Export Citation Format

Share Document